Position in AMGN
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$1,756,643
+$139,189 QoQ
Shares Held
4,851
+5.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.91%
of 13F equity value
Holder Rank
#1,352
of 3,139 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 55%
Shared 45%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Argyle Capital Partners, LLC holds $5,444,856 across 5 Drug Manufacturers - General names. AMGN ranks #2 (32.3% of the industry book) .
All Filings in AMGN
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,756,643 | 4,851 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $1,617,454 | 4,597 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $1,602,509 | 4,896 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,569,878 | 5,563 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,411,127 | 5,054 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $1,613,829 | 5,180 | Shares | Sole | 2025-08-13 | |
| 2024-12-31 | $1,386,865 | 5,321 | Shares | Sole | 2025-08-13 | |
| No filing history on record for this holder in this stock. | ||||||